Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MICRO THERAPEUTICS' LIQUID EMBOLIC SYSTEM TO ENTER CLINICALS EARLY IN 1997; FIRM EXPECTS $21.8 MIL. IN NET PROCEEDS FROM 2 MIL. SHARE INITIAL PUBLIC OFFERING

This article was originally published in The Gray Sheet

Executive Summary

Micro Therapeutics' Liquid Embolic System for treatment of arteriovenous malformations (AVMs) and aneurysms in the brain is anticipated to enter clinical trials in the first half of 1997, the firm says in a registration statement for an initial public offering.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007363

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel